NPORT-EX 2 QTLY_2610_20210228.htm

Quarterly Holdings Report
for

Fidelity® Series Growth Company Fund

February 28, 2021







XS7-QTLY-0421
1.968012.107





Schedule of Investments February 28, 2021 (Unaudited)

Showing Percentage of Net Assets

Common Stocks - 95.4%   
 Shares Value 
COMMUNICATION SERVICES - 11.6%   
Entertainment - 3.7%   
Activision Blizzard, Inc. 446,328 $42,673,420 
Electronic Arts, Inc. 77,754 10,416,703 
NetEase, Inc. ADR 86,420 9,493,237 
Netflix, Inc. (a) 159,229 85,800,547 
Nintendo Co. Ltd. 8,330 5,094,401 
Roku, Inc. Class A (a) 572,376 226,363,260 
Sea Ltd. ADR (a) 360,285 84,915,572 
Skillz, Inc. (b) 106,370 3,362,356 
The Walt Disney Co. (a) 128,476 24,287,103 
Zynga, Inc. (a) 211,200 2,354,880 
  494,761,479 
Interactive Media & Services - 7.4%   
Alphabet, Inc.:   
Class A (a) 223,199 451,288,290 
Class C (a) 127,143 258,972,491 
Bumble, Inc. 62,000 4,173,220 
Facebook, Inc. Class A (a) 755,130 194,536,591 
IAC (a) 37,300 9,132,159 
Kuaishou Technology Class B (c) 122,400 4,872,992 
Match Group, Inc. (a) 10,153 1,551,886 
Pinterest, Inc. Class A (a) 33,800 2,723,604 
Snap, Inc. Class A (a) 424,881 27,897,686 
Tencent Holdings Ltd. 90,190 7,846,261 
Twitter, Inc. (a) 144,481 11,133,706 
Zillow Group, Inc. Class C (a)(d) 140,700 22,699,131 
  996,828,017 
Media - 0.0%   
Comcast Corp. Class A 42,610 2,246,399 
Wireless Telecommunication Services - 0.5%   
T-Mobile U.S., Inc. 614,453 73,715,926 
TOTAL COMMUNICATION SERVICES  1,567,551,821 
CONSUMER DISCRETIONARY - 21.7%   
Auto Components - 0.1%   
QuantumScape Corp. (b) 173,898 8,596,995 
Automobiles - 2.5%   
Lordstown Motors Corp. (a) 320,264 6,193,906 
Neutron Holdings, Inc. (e) 438,358 6,488 
Rad Power Bikes, Inc. (b)(e) 249,183 1,202,019 
Tesla, Inc. (a) 468,885 316,731,818 
XPeng, Inc. ADR (a)(d) 173,700 5,924,907 
  330,059,138 
Hotels, Restaurants & Leisure - 1.5%   
Airbnb, Inc. Class A (d) 6,800 1,403,180 
Chipotle Mexican Grill, Inc. (a) 10,570 15,241,940 
Hyatt Hotels Corp. Class A 28,183 2,478,695 
Marriott International, Inc. Class A 258,050 38,209,464 
McDonald's Corp. 9,525 1,963,484 
NeoGames SA 16,500 500,445 
Penn National Gaming, Inc. (a) 566,000 65,531,480 
Planet Fitness, Inc. (a) 16,032 1,380,195 
Rush Street Interactive, Inc. (a) 313,400 4,867,102 
Rush Street Interactive, Inc. (b) 102,555 1,592,679 
Shake Shack, Inc. Class A (a)(d) 14,936 1,769,617 
Starbucks Corp. 435,853 47,085,200 
Vail Resorts, Inc. 44,400 13,727,592 
Yum China Holdings, Inc. 131,012 7,839,758 
  203,590,831 
Household Durables - 0.8%   
D.R. Horton, Inc. 273,910 21,055,462 
KB Home 271,450 10,961,151 
Lennar Corp. Class A 677,069 56,176,415 
PulteGroup, Inc. 49,500 2,232,945 
Toll Brothers, Inc. 334,100 17,847,622 
  108,273,595 
Internet & Direct Marketing Retail - 8.8%   
Alibaba Group Holding Ltd. sponsored ADR (a) 198,829 47,273,583 
Amazon.com, Inc. (a) 250,818 775,762,517 
Doordash, Inc. 1,400 237,286 
Etsy, Inc. (a) 48,381 10,656,883 
Farfetch Ltd. Class A (a) 103,250 6,802,110 
JD.com, Inc. sponsored ADR (a) 383,629 36,011,254 
Ocado Group PLC (a) 529,720 16,236,130 
Ozon Holdings PLC ADR (d) 46,600 2,765,710 
Pinduoduo, Inc. ADR (a) 22,000 3,765,520 
Revolve Group, Inc. (a) 212,700 9,805,470 
The Booking Holdings, Inc. (a) 16,472 38,355,217 
The Honest Co., Inc. (a)(b)(e) 9,496 251,350 
The RealReal, Inc. (a) 276,318 7,057,162 
THG PLC 362,000 3,570,716 
Wayfair LLC Class A (a)(d) 809,570 233,949,539 
Zomato Pvt Ltd. (b)(e) 151 796,489 
  1,193,296,936 
Leisure Products - 0.3%   
Peloton Interactive, Inc. Class A (a) 305,342 36,784,551 
Multiline Retail - 0.4%   
Dollar General Corp. 39,540 7,472,665 
Dollar Tree, Inc. (a) 51,594 5,066,531 
Ollie's Bargain Outlet Holdings, Inc. (a)(d) 386,689 31,971,447 
Target Corp. 80,413 14,750,961 
  59,261,604 
Specialty Retail - 2.5%   
Auto1 Group SE (c) 61,200 3,396,680 
Carvana Co. Class A (a) 226,424 64,191,204 
Cazoo Holdings Ltd. (b)(e) 48,980 725,039 
Five Below, Inc. (a) 49,700 9,250,164 
Floor & Decor Holdings, Inc. Class A (a) 226,700 21,556,903 
Lowe's Companies, Inc. 422,823 67,545,974 
MYT Netherlands Parent BV ADR (d) 35,900 1,037,151 
RH (a)(d) 145,834 71,512,619 
The Home Depot, Inc. 239,077 61,763,152 
TJX Companies, Inc. 456,872 30,148,983 
Williams-Sonoma, Inc. 55,900 7,339,111 
  338,466,980 
Textiles, Apparel & Luxury Goods - 4.8%   
adidas AG 173,298 60,406,881 
Allbirds, Inc. (a)(b)(e) 81,240 939,134 
Canada Goose Holdings, Inc. (a)(d) 366,771 16,439,272 
Deckers Outdoor Corp. (a) 72,370 23,600,581 
Dr. Martens Ltd. (a) 1,018,300 6,999,844 
lululemon athletica, Inc. (a) 1,250,180 389,656,102 
NIKE, Inc. Class B 391,454 52,760,170 
On Holding AG (b)(e) 288 5,606,196 
Skechers U.S.A., Inc. Class A (sub. vtg.) (a) 1,871,479 68,496,131 
Tory Burch LLC (a)(b)(e)(f) 248,840 18,401,718 
Under Armour, Inc. Class C (non-vtg.) (a) 120,872 2,199,870 
VF Corp. 25,599 2,025,649 
  647,531,548 
TOTAL CONSUMER DISCRETIONARY  2,925,862,178 
CONSUMER STAPLES - 2.1%   
Beverages - 0.9%   
Boston Beer Co., Inc. Class A (a) 3,958 4,071,634 
Fever-Tree Drinks PLC 165,077 5,241,364 
Keurig Dr. Pepper, Inc. 544,571 16,620,307 
Monster Beverage Corp. (a) 528,335 46,356,113 
PepsiCo, Inc. 70,664 9,129,082 
The Coca-Cola Co. 782,107 38,315,422 
  119,733,922 
Food & Staples Retailing - 0.4%   
Blink Health, Inc. Series A1 (b)(e) 8,589 280,345 
Costco Wholesale Corp. 123,144 40,760,664 
Kroger Co. 8,640 278,294 
Performance Food Group Co. (a) 218,868 11,871,400 
Walgreens Boots Alliance, Inc. 78,300 3,752,919 
  56,943,622 
Food Products - 0.4%   
Archer Daniels Midland Co. 67,200 3,802,176 
Beyond Meat, Inc. (a)(d) 14,100 2,051,268 
Bunge Ltd. 289,454 22,166,387 
Darling Ingredients, Inc. (a) 223,369 14,081,182 
Freshpet, Inc. (a) 23,750 3,702,150 
JDE Peet's BV 62,800 2,549,706 
Laird Superfood, Inc. 84,300 3,327,321 
Mondelez International, Inc. 23,117 1,228,900 
  52,909,090 
Household Products - 0.2%   
Church & Dwight Co., Inc. 39,421 3,104,404 
Colgate-Palmolive Co. 60,491 4,548,923 
Procter & Gamble Co. 138,878 17,155,599 
  24,808,926 
Personal Products - 0.0%   
Unilever PLC 7,236 375,896 
Yatsen Holding Ltd. ADR 23,200 406,696 
  782,592 
Tobacco - 0.2%   
Altria Group, Inc. 552,850 24,104,260 
JUUL Labs, Inc. Class A (a)(b)(e) 13,297 1,019,880 
Philip Morris International, Inc. 57,500 4,831,150 
RLX Technology, Inc. ADR 106,800 1,870,068 
  31,825,358 
TOTAL CONSUMER STAPLES  287,003,510 
ENERGY - 0.8%   
Energy Equipment & Services - 0.2%   
Halliburton Co. 513,400 11,207,522 
Schlumberger Ltd. 489,900 13,673,109 
  24,880,631 
Oil, Gas & Consumable Fuels - 0.6%   
EOG Resources, Inc. 22,600 1,459,056 
Hess Corp. 714,006 46,788,813 
Pioneer Natural Resources Co. 24,500 3,639,965 
Reliance Industries Ltd. 948,431 26,755,716 
Reliance Industries Ltd. 63,228 1,035,386 
  79,678,936 
TOTAL ENERGY  104,559,567 
FINANCIALS - 1.7%   
Banks - 0.9%   
Bank of America Corp. 931,217 32,322,542 
First Republic Bank 53,800 8,863,550 
HDFC Bank Ltd. sponsored ADR (a) 322,122 25,492,735 
JPMorgan Chase & Co. 316,223 46,538,539 
Wells Fargo & Co. 378,900 13,704,813 
  126,922,179 
Capital Markets - 0.6%   
Aspirational Consumer Lifestyle Corp. Class A (a) 8,600 93,998 
B3 SA - Brasil Bolsa Balcao 1,296,400 12,561,029 
BlackRock, Inc. Class A 43,897 30,486,467 
Charles Schwab Corp. 472,651 29,172,020 
Edelweiss Financial Services Ltd. (a) 613,687 573,124 
Vesper Healthcare Acquisition Corp. Class A (a) 98,100 1,083,024 
  73,969,662 
Consumer Finance - 0.0%   
Discover Financial Services 15,482 1,456,392 
Diversified Financial Services - 0.2%   
Ant International Co. Ltd. Class C (a)(b)(e) 419,242 2,255,522 
AppHarvest, Inc. (b) 485,276 14,037,821 
Coinbase, Inc. (a)(b)(e) 10,300 3,841,900 
Decarbonization Plus Acquisition Corp. Class A (a) 19,800 233,046 
Gemini Therapeutics, Inc. (b) 132,041 1,906,672 
Gemini Therapeutics, Inc. 14,200 215,840 
Nuvation Bio, Inc. (b) 423,184 3,820,082 
  26,310,883 
TOTAL FINANCIALS  228,659,116 
HEALTH CARE - 17.0%   
Biotechnology - 9.5%   
4D Molecular Therapeutics, Inc. 39,100 1,641,418 
AbbVie, Inc. 88,149 9,497,173 
ACADIA Pharmaceuticals, Inc. (a) 1,379,671 67,562,489 
ADC Therapeutics SA (a) 168,400 4,477,756 
Akouos, Inc. (a) 216,200 4,403,994 
Akouos, Inc. (c) 113,263 2,307,167 
Alector, Inc. (a)(d) 175,860 3,197,135 
Allovir, Inc. (a) 465,510 17,019,046 
Alnylam Pharmaceuticals, Inc. (a) 816,831 120,972,671 
ALX Oncology Holdings, Inc. (a) 24,200 1,943,018 
Amgen, Inc. 157,404 35,403,308 
Annexon, Inc. (a) 40,000 1,164,400 
Arcutis Biotherapeutics, Inc. (a) 190,600 6,512,802 
Argenx SE ADR (a) 132,960 43,967,213 
Arrowhead Pharmaceuticals, Inc. (a) 22,259 1,773,152 
Ascendis Pharma A/S sponsored ADR (a) 24,489 3,795,060 
aTyr Pharma, Inc. (a) 92,079 400,544 
Avidity Biosciences, Inc. 213,500 5,151,755 
Axcella Health, Inc. (a) 560,401 3,194,286 
BeiGene Ltd. ADR (a) 325,782 104,250,240 
BioAtla, Inc. 176,719 9,383,779 
Biogen, Inc. (a) 2,442 666,373 
BioNTech SE ADR (a)(d) 135,402 14,762,880 
BioXcel Therapeutics, Inc. (a)(d) 161,898 8,679,352 
Bolt Biotherapeutics, Inc. 52,000 1,388,400 
BridgeBio Pharma, Inc. (a)(d) 37,702 2,664,777 
Burning Rock Biotech Ltd. ADR 10,300 370,697 
C4 Therapeutics, Inc. 12,800 549,376 
Calyxt, Inc. (a) 238,281 2,273,201 
Cerevel Therapeutics Holdings (a)(d) 75,200 1,140,032 
Cerevel Therapeutics Holdings (b) 317,700 4,816,332 
ChemoCentryx, Inc. (a) 707,639 48,006,230 
Cibus Corp. Series C (a)(b)(e)(f) 1,893,817 2,878,602 
Codiak Biosciences, Inc. 189,968 2,923,608 
Codiak Biosciences, Inc. 116,000 1,879,200 
CRISPR Therapeutics AG (a) 10,100 1,269,469 
Cullinan Oncology, Inc. 21,700 877,114 
Cyclerion Therapeutics, Inc. (a) 59,847 229,812 
Cyclerion Therapeutics, Inc. (a)(b) 150,550 578,112 
Denali Therapeutics, Inc. (a) 74,374 5,340,053 
Evelo Biosciences, Inc. (a)(d) 613,614 7,467,682 
Exact Sciences Corp. (a) 32,639 4,442,821 
Exelixis, Inc. (a) 41,373 896,139 
Fate Therapeutics, Inc. (a) 535,316 48,028,552 
Foghorn Therapeutics, Inc. 73,500 1,209,810 
Foghorn Therapeutics, Inc. 78,183 1,222,548 
Fusion Pharmaceuticals, Inc. (a) 81,380 950,518 
Generation Bio Co. 518,560 18,108,115 
Homology Medicines, Inc. (a) 45,549 489,196 
Immunocore Holdings PLC 101,170 4,403,323 
Immunocore Holdings PLC ADR 52,000 2,514,720 
Inhibrx, Inc. (a) 113,900 2,895,338 
Intarcia Therapeutics, Inc. warrants 12/6/24 (a)(e) 7,022 1 
Ionis Pharmaceuticals, Inc. (a) 1,699,834 89,071,302 
Iovance Biotherapeutics, Inc. (a) 18,337 683,970 
Ironwood Pharmaceuticals, Inc. Class A (a)(d) 61,941 571,715 
iTeos Therapeutics, Inc. (a) 42,000 1,746,360 
Karuna Therapeutics, Inc. (a)(d) 385,399 48,159,459 
Keros Therapeutics, Inc. 59,100 3,869,277 
Kinnate Biopharma, Inc. 58,600 1,958,998 
Kronos Bio, Inc. (d) 51,300 1,491,291 
Kronos Bio, Inc. 59,071 1,631,334 
Kura Oncology, Inc. (a) 38,600 1,080,800 
Kymera Therapeutics, Inc. (a) 26,800 1,285,864 
Lexicon Pharmaceuticals, Inc. (a) 568,422 4,086,954 
Moderna, Inc. (a) 330,741 51,202,014 
Morphic Holding, Inc. (a) 227,151 8,213,780 
Novavax, Inc. (a) 123,600 28,580,028 
Nuvation Bio Pvt, Inc. 678,953 6,128,909 
Olema Pharmaceuticals, Inc. 49,900 1,992,008 
ORIC Pharmaceuticals, Inc. (a) 153,948 4,987,915 
Passage Bio, Inc. 127,790 2,302,776 
Poseida Therapeutics, Inc. (a) 292,808 3,232,600 
Poseida Therapeutics, Inc. (c) 214,051 2,363,123 
Praxis Precision Medicines, Inc. 347,800 15,129,300 
Prelude Therapeutics, Inc. 65,000 4,051,450 
Protagonist Therapeutics, Inc. (a) 233,895 5,512,905 
Prothena Corp. PLC (a) 165,105 3,685,144 
PTC Therapeutics, Inc. (a) 146,730 8,378,283 
Regeneron Pharmaceuticals, Inc. (a) 72,321 32,585,673 
Relay Therapeutics, Inc. (a) 112,200 4,630,494 
Repare Therapeutics, Inc. 20,800 684,320 
Repligen Corp. (a) 29,900 6,350,461 
Revolution Medicines, Inc. 194,760 8,896,637 
Rigel Pharmaceuticals, Inc. (a)(d) 2,019,599 8,381,336 
Rubius Therapeutics, Inc. (a)(d) 996,117 10,339,694 
Sage Therapeutics, Inc. (a) 585,982 49,808,470 
Sana Biotechnology, Inc. 12,000 368,880 
Sarepta Therapeutics, Inc. (a) 32,637 2,841,377 
Scholar Rock Holding Corp. (a)(d) 302,434 16,361,679 
Seagen, Inc. (a) 9,100 1,375,101 
Seer, Inc. (d) 213,283 10,286,639 
Seres Therapeutics, Inc. (a) 913,626 17,395,439 
Shattuck Labs, Inc. 257,739 10,644,621 
Sigilon Therapeutics, Inc. 63,800 1,697,080 
Silverback Therapeutics, Inc. (d) 320,885 15,421,733 
Silverback Therapeutics, Inc. 34,299 1,483,569 
Springworks Therapeutics, Inc. (a) 254,600 21,908,330 
Spruce Biosciences, Inc. 40,900 854,810 
Stoke Therapeutics, Inc. (a) 16,200 970,218 
Syros Pharmaceuticals, Inc. (a) 702,838 5,903,839 
Syros Pharmaceuticals, Inc. (a)(c) 301,001 2,528,408 
Syros Pharmaceuticals, Inc. warrants 10/10/22 (a) 35,253 71,357 
Taysha Gene Therapies, Inc. 191,824 4,908,776 
Taysha Gene Therapies, Inc. 85,584 2,080,590 
TG Therapeutics, Inc. (a) 183,200 8,018,664 
Translate Bio, Inc. (a) 383,299 8,946,199 
Turning Point Therapeutics, Inc. (a) 19,190 2,262,693 
Twist Bioscience Corp. (a) 19,300 2,656,452 
Ultragenyx Pharmaceutical, Inc. (a) 13,752 1,946,458 
uniQure B.V. (a) 192,006 7,046,620 
UNITY Biotechnology, Inc. (a)(d) 384,307 2,617,131 
Vaxcyte, Inc. 238,380 5,616,233 
Vertex Pharmaceuticals, Inc. (a) 32,793 6,970,152 
Vor Biopharma, Inc. 92,011 3,723,133 
Vor Biopharma, Inc. (a) 59,700 2,684,112 
Xencor, Inc. (a) 260,862 12,852,671 
Yumanity Therapeutics, Inc. (b) 19,530 347,048 
Yumanity Therapeutics, Inc. 73,696 1,178,620 
Zai Lab Ltd. ADR (a) 198,386 29,265,903 
Zentalis Pharmaceuticals, Inc. 73,160 3,075,646 
  1,281,325,614 
Health Care Equipment & Supplies - 3.2%   
Abbott Laboratories 76,901 9,211,202 
Danaher Corp. 199,633 43,853,381 
DexCom, Inc. (a) 112,621 44,798,381 
Genmark Diagnostics, Inc. (a) 249,501 4,877,745 
Insulet Corp. (a) 397,483 102,987,845 
Intuitive Surgical, Inc. (a) 60,841 44,827,649 
Novocure Ltd. (a) 703,007 104,818,344 
Outset Medical, Inc. 103,361 5,146,344 
Outset Medical, Inc. 168,553 7,972,641 
Penumbra, Inc. (a) 89,252 25,385,946 
Presbia PLC (a)(e) 454,926 4,549 
Pulmonx Corp. 900 51,147 
Shockwave Medical, Inc. (a) 264,367 30,867,491 
  424,802,665 
Health Care Providers & Services - 1.1%   
1Life Healthcare, Inc. (a) 234,700 11,150,597 
Alignment Healthcare Partners unit (b)(e) 233,968 4,380,349 
Centene Corp. (a) 151,190 8,850,663 
Clover Health Investments Corp. (b) 202,600 1,904,440 
Clover Health Investments Corp. Class B 509,299 4,308,670 
CVS Health Corp. 81,100 5,525,343 
Humana, Inc. 13,943 5,293,460 
Oak Street Health, Inc. (a) 231,856 12,295,324 
Progyny, Inc. (a) 55,800 2,348,622 
Signify Health, Inc. 33,100 1,092,962 
UnitedHealth Group, Inc. 282,854 93,969,756 
  151,120,186 
Health Care Technology - 0.0%   
Castlight Health, Inc. Class B (a) 549,960 934,932 
GoodRx Holdings, Inc. 35,900 1,598,268 
  2,533,200 
Life Sciences Tools & Services - 1.7%   
10X Genomics, Inc. (a) 204,701 36,434,731 
10X Genomics, Inc. Class B (c) 640,857 114,066,137 
AbCellera Biologics, Inc. (d) 8,800 331,848 
Adaptive Biotechnologies Corp. (a) 22,517 1,273,787 
Berkeley Lights, Inc. (a) 500 30,985 
Bruker Corp. 63,723 3,885,829 
Nanostring Technologies, Inc. (a) 108,634 7,581,567 
Sartorius Stedim Biotech 5,600 2,445,918 
Seer, Inc. 156,157 6,778,307 
Seer, Inc. Class A (b) 75,433 3,638,134 
Sotera Health Co. 16,300 426,245 
Thermo Fisher Scientific, Inc. 52,474 23,617,498 
WuXi AppTec Co. Ltd. (H Shares) (c) 222,900 4,646,833 
Wuxi Biologics (Cayman), Inc. (a)(c) 1,700,810 21,071,201 
  226,229,020 
Pharmaceuticals - 1.5%   
Adimab LLC (a)(b)(e)(f) 762,787 38,740,045 
Arvinas Holding Co. LLC (a) 36,400 2,850,120 
Atea Pharmaceuticals, Inc. (d) 673,430 50,749,685 
Bristol-Myers Squibb Co. 102,565 6,290,311 
Dragonfly Therapeutics, Inc. (a)(b)(e) 126,113 3,487,024 
Fulcrum Therapeutics, Inc. (a)(d) 169,855 2,141,872 
Hansoh Pharmaceutical Group Co. Ltd. (a)(c) 496,400 2,527,935 
Harmony Biosciences Holdings, Inc. (c) 9,716 344,627 
Harmony Biosciences Holdings, Inc. (a) 433,507 15,376,493 
Intra-Cellular Therapies, Inc. (a) 882,209 31,256,665 
Jiangsu Hengrui Medicine Co. Ltd. (A Shares) 35,976 565,602 
Kaleido Biosciences, Inc. (a) 483,072 4,313,833 
Nektar Therapeutics (a) 475,322 10,785,056 
OptiNose, Inc. (a) 678,975 2,634,423 
Pharvaris BV 38,100 1,447,419 
Pliant Therapeutics, Inc. 154,336 5,106,978 
Royalty Pharma PLC (a)(b)(e) 2,548 0 
Royalty Pharma PLC 70,700 3,292,499 
Royalty Pharma PLC (c) 326,720 15,215,350 
Sienna Biopharmaceuticals, Inc. (a) 595,618 11,912 
Stemcentrx, Inc. rights 12/31/21 (a)(e) 568,100 6 
Theravance Biopharma, Inc. (a) 501,245 8,305,630 
UCB SA 22,100 2,198,242 
  207,641,727 
TOTAL HEALTH CARE  2,293,652,412 
INDUSTRIALS - 5.3%   
Aerospace & Defense - 0.5%   
Axon Enterprise, Inc. (a) 12,960 2,144,750 
Space Exploration Technologies Corp. Class A (a)(b)(e) 137,569 57,777,604 
The Boeing Co. 17,336 3,675,405 
  63,597,759 
Air Freight & Logistics - 0.3%   
FedEx Corp. 76,300 19,418,350 
United Parcel Service, Inc. Class B 125,884 19,868,272 
  39,286,622 
Airlines - 1.7%   
Delta Air Lines, Inc. 799,390 38,322,757 
JetBlue Airways Corp. (a) 1,960,414 36,130,430 
Ryanair Holdings PLC sponsored ADR (a) 46,378 4,986,563 
Southwest Airlines Co. 1,116,437 64,898,483 
Spirit Airlines, Inc. (a) 288,033 10,334,624 
United Airlines Holdings, Inc. (a) 437,625 23,054,085 
Wheels Up Partners Holdings LLC Series B (a)(b)(f) 3,649,665 15,620,566 
Wizz Air Holdings PLC (a)(c) 441,083 32,630,844 
  225,978,352 
Building Products - 0.2%   
Carrier Global Corp. 51,200 1,870,336 
Resideo Technologies, Inc. (a) 123,100 2,956,862 
The AZEK Co., Inc. 67,460 2,975,661 
Trane Technologies PLC 139,222 21,334,379 
  29,137,238 
Electrical Equipment - 0.3%   
AMETEK, Inc. 30,707 3,622,505 
Eaton Corp. PLC 39,224 5,106,573 
Emerson Electric Co. 106,649 9,161,149 
Generac Holdings, Inc. (a) 50,800 16,741,648 
Rockwell Automation, Inc. 24,600 5,984,688 
Shoals Technologies Group, Inc. 87,400 2,850,988 
  43,467,551 
Industrial Conglomerates - 0.3%   
3M Co. 98,980 17,327,439 
Honeywell International, Inc. 84,183 17,034,430 
  34,361,869 
Machinery - 0.9%   
Caterpillar, Inc. 112,360 24,256,277 
Cummins, Inc. 41,600 10,533,120 
Deere & Co. 131,252 45,822,698 
Fortive Corp. 89,608 5,897,999 
Illinois Tool Works, Inc. 44,953 9,088,598 
Ingersoll Rand, Inc. (a) 52,144 2,416,353 
Nikola Corp. (a)(d) 187,621 3,395,940 
Xylem, Inc. 198,917 19,804,177 
  121,215,162 
Professional Services - 0.0%   
CoStar Group, Inc. (a) 1,628 1,341,081 
Road & Rail - 1.1%   
Avis Budget Group, Inc. (a) 85,362 4,741,859 
CSX Corp. 78,100 7,150,055 
Kansas City Southern 31,200 6,625,008 
Lyft, Inc. (a) 340,268 18,952,928 
Uber Technologies, Inc. (a) 1,236,604 63,994,257 
Union Pacific Corp. 254,261 52,367,596 
  153,831,703 
TOTAL INDUSTRIALS  712,217,337 
INFORMATION TECHNOLOGY - 34.0%   
Communications Equipment - 0.4%   
Arista Networks, Inc. (a) 6,833 1,912,147 
Ciena Corp. (a) 409,297 21,353,024 
Infinera Corp. (a)(d) 2,637,275 25,911,227 
Lumentum Holdings, Inc. (a) 70,080 6,307,200 
  55,483,598 
Electronic Equipment & Components - 0.3%   
908 Devices, Inc. 32,000 1,702,080 
Arlo Technologies, Inc. (a) 223,011 1,552,157 
II-VI, Inc. (a) 211,990 17,870,757 
TE Connectivity Ltd. 2,741 356,412 
Trimble, Inc. (a) 186,600 13,834,524 
Vontier Corp. (a) 19,163 601,718 
  35,917,648 
IT Services - 6.6%   
Accenture PLC Class A 25,500 6,397,950 
Actua Corp. (a)(e) 562,258 28,113 
Affirm Holdings, Inc. (d) 12,900 1,200,474 
BigCommerce Holdings, Inc. (a)(d) 11,100 656,121 
Black Knight, Inc. (a) 77,470 5,941,174 
IBM Corp. 5,395 641,627 
MasterCard, Inc. Class A 303,049 107,233,889 
MongoDB, Inc. Class A (a) 4,841 1,868,287 
Nuvei Corp. (a)(c) 31,800 1,655,190 
Okta, Inc. (a) 35,481 9,276,507 
PayPal Holdings, Inc. (a) 835,727 217,163,661 
Riskified Ltd. (a)(b)(e) 196,150 2,255,725 
Riskified Ltd. warrants (a)(b)(e) 1,301 1 
Shopify, Inc. Class A (a) 263,549 341,443,614 
Snowflake Computing, Inc. 6,200 1,609,148 
Snowflake Computing, Inc.:   
Class B 5,944 1,465,570 
Class B (c) 1,981 514,149 
Square, Inc. (a) 274,685 63,185,791 
TELUS International, Inc. 46,600 1,357,458 
Twilio, Inc. Class A (a) 1,100 432,168 
Visa, Inc. Class A 533,612 113,333,853 
Wix.com Ltd. (a) 23,068 8,040,813 
Worldline SA (a)(c) 61,100 5,440,551 
  891,141,834 
Semiconductors & Semiconductor Equipment - 10.1%   
Advanced Micro Devices, Inc. (a) 1,118,193 94,498,490 
Applied Materials, Inc. 349,785 41,341,089 
Array Technologies, Inc. 45,400 1,683,432 
ASML Holding NV 71,085 40,311,593 
Broadcom, Inc. 27,125 12,745,224 
Cirrus Logic, Inc. (a) 338,066 27,647,037 
Cree, Inc. (a) 56,029 6,357,050 
First Solar, Inc. (a) 117,200 9,495,544 
Intel Corp. 54,262 3,298,044 
KLA Corp. 40,886 12,724,950 
Marvell Technology Group Ltd. 592,441 28,603,051 
Micron Technology, Inc. (a) 363,031 33,228,227 
NVIDIA Corp. 1,609,935 883,178,132 
Qualcomm, Inc. 173,509 23,630,191 
Silicon Laboratories, Inc. (a) 603,889 94,049,673 
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR 233,768 29,440,742 
Teradyne, Inc. 52,250 6,719,873 
Texas Instruments, Inc. 114,994 19,810,016 
Xilinx, Inc. 25,100 3,270,530 
  1,372,032,888 
Software - 10.2%   
2U, Inc. (a)(d) 52,309 2,073,006 
Adobe, Inc. (a) 166,712 76,632,505 
Agora, Inc. ADR (a)(d) 4,800 292,176 
Atlassian Corp. PLC (a) 15,326 3,642,990 
Autodesk, Inc. (a) 124,442 34,345,992 
Avalara, Inc. (a) 20,104 3,155,122 
Bill.Com Holdings, Inc. (a) 4,800 792,048 
BTRS Holdings, Inc. (b) 132,061 2,231,831 
Cloudflare, Inc. (a) 1,244,081 92,024,672 
Coupa Software, Inc. (a) 12,804 4,433,513 
Crowdstrike Holdings, Inc. (a) 28,433 6,141,528 
Datadog, Inc. Class A (a) 9,630 918,798 
DocuSign, Inc. (a) 12,191 2,763,212 
Elastic NV (a) 41,394 5,562,940 
Epic Games, Inc. (b)(e) 11,800 6,785,000 
HubSpot, Inc. (a) 109,917 56,607,255 
Intuit, Inc. 72,594 28,321,823 
JFrog Ltd. (d) 13,500 722,115 
Lightspeed POS, Inc. 84,700 5,795,174 
LivePerson, Inc. (a) 176,844 11,604,503 
Medallia, Inc. (a)(d) 44,729 1,805,710 
Microsoft Corp. 2,319,236 538,944,062 
Nutanix, Inc. Class A (a) 2,608,357 78,994,092 
Oracle Corp. 345,304 22,275,561 
Paycom Software, Inc. (a) 11,800 4,416,032 
Paylocity Holding Corp. (a) 15,897 3,039,347 
Qualtrics International, Inc. 5,800 220,400 
RingCentral, Inc. (a) 8,642 3,268,059 
Salesforce.com, Inc. (a) 1,434,984 310,674,036 
Slack Technologies, Inc. Class A (a) 47,200 1,931,896 
The Trade Desk, Inc. (a) 1,800 1,449,702 
Workday, Inc. Class A (a) 20,432 5,009,518 
Zendesk, Inc. (a) 188,795 27,590,501 
Zoom Video Communications, Inc. Class A (a) 52,353 19,559,604 
Zscaler, Inc. (a) 61,265 12,561,163 
  1,376,585,886 
Technology Hardware, Storage & Peripherals - 6.4%   
Apple, Inc. 6,774,728 821,503,517 
Pure Storage, Inc. Class A (a) 1,558,058 36,427,396 
Samsung Electronics Co. Ltd. 92,763 6,787,386 
  864,718,299 
TOTAL INFORMATION TECHNOLOGY  4,595,880,153 
MATERIALS - 1.0%   
Chemicals - 0.3%   
Albemarle Corp. U.S. 9,000 1,414,890 
Corteva, Inc. 687,900 31,058,685 
Dow, Inc. 63,059 3,740,029 
DuPont de Nemours, Inc. 157,046 11,043,475 
The Mosaic Co. 41,800 1,228,920 
  48,485,999 
Containers & Packaging - 0.2%   
Ball Corp. 195,700 16,710,823 
Sealed Air Corp. 141,000 5,907,900 
  22,618,723 
Metals & Mining - 0.5%   
Barrick Gold Corp. (Canada) 568,600 10,611,543 
Freeport-McMoRan, Inc. 1,411,500 47,863,965 
Rio Tinto PLC sponsored ADR 79,100 6,913,340 
  65,388,848 
TOTAL MATERIALS  136,493,570 
REAL ESTATE - 0.2%   
Equity Real Estate Investment Trusts (REITs) - 0.1%   
American Tower Corp. 50,198 10,849,294 
Simon Property Group, Inc. 87,300 9,857,916 
  20,707,210 
Real Estate Management & Development - 0.1%   
KE Holdings, Inc. ADR (a)(d) 188,000 12,000,040 
TOTAL REAL ESTATE  32,707,250 
TOTAL COMMON STOCKS   
(Cost $3,992,945,715)  12,884,586,914 
Preferred Stocks - 1.6%   
Convertible Preferred Stocks - 1.5%   
COMMUNICATION SERVICES - 0.0%   
Diversified Telecommunication Services - 0.0%   
Starry, Inc.:   
Series B (a)(b)(e) 2,961,147 4,234,440 
Series C (a)(b)(e) 1,339,018 1,914,796 
Series D (a)(b)(e) 1,344,355 1,922,428 
  8,071,664 
CONSUMER DISCRETIONARY - 0.4%   
Automobiles - 0.2%   
Rad Power Bikes, Inc.:   
Series A (b)(e) 32,487 156,712 
Series C (b)(e) 127,831 616,636 
Rivian Automotive, Inc.:   
Series E (b)(e) 625,451 23,047,869 
Series F (b)(e) 232,868 8,581,186 
  32,402,403 
Hotels, Restaurants & Leisure - 0.1%   
MOD Super Fast Pizza Holdings LLC Series 3 (a)(b)(e)(f) 23,686 4,761,999 
Topgolf International, Inc. Series F (a)(b) 234,069 5,484,237 
  10,246,236 
Internet & Direct Marketing Retail - 0.1%   
Instacart, Inc.:   
Series H (b)(e) 13,904 1,738,000 
Series I (b)(e) 6,341 792,625 
Reddit, Inc. Series B (a)(b)(e) 37,935 1,611,259 
The Honest Co., Inc.:   
Series C (a)(b)(e) 22,157 674,446 
Series D (a)(b)(e) 19,064 580,297 
Zomato Pvt Ltd.:   
Series B (b)(e) 6 31,649 
Series E (b)(e) 40,194 21 
Series G (b)(e) 41 216,265 
Series J7 (b)(e) 310 1,635,176 
Series K (b)(e) 492 2,595,182 
  9,874,920 
Specialty Retail - 0.0%   
Fanatics, Inc. Series E (b)(e) 127,722 2,208,313 
Textiles, Apparel & Luxury Goods - 0.0%   
Allbirds, Inc.:   
Series A (a)(b)(e) 32,065 370,671 
Series B (a)(b)(e) 5,635 65,141 
Series C (a)(b)(e) 53,835 622,333 
Series D (a)(b)(e) 62,760 725,506 
Series Seed (a)(b)(e) 99,244 1,147,261 
Freenome, Inc. Series C (b)(e) 190,858 1,498,235 
  4,429,147 
TOTAL CONSUMER DISCRETIONARY  59,161,019 
CONSUMER STAPLES - 0.1%   
Food & Staples Retailing - 0.1%   
Blink Health, Inc. Series C (a)(b)(e) 182,443 5,954,940 
Sweetgreen, Inc.:   
Series C (a)(b)(e) 1,331 17,503 
Series D (a)(b)(e) 21,414 281,594 
Series H (a)(b)(e) 168,337 2,213,632 
Series I (a)(b)(e) 50,469 663,667 
  9,131,336 
Food Products - 0.0%   
Agbiome LLC Series C (a)(b)(e) 338,565 2,144,369 
Tobacco - 0.0%   
JUUL Labs, Inc. Series E (a)(b)(e) 6,648 509,902 
TOTAL CONSUMER STAPLES  11,785,607 
FINANCIALS - 0.1%   
Diversified Financial Services - 0.1%   
Paragon Biosciences Emalex Capital, Inc.:   
Series B (a)(b)(e) 198,234 2,121,104 
Series C (b)(e) 115,792 1,238,974 
Sonder Holdings, Inc.:   
Series D1 (b)(e) 265,415 2,857,697 
Series E (b)(e) 420,126 4,523,455 
  10,741,230 
HEALTH CARE - 0.3%   
Biotechnology - 0.2%   
23andMe, Inc. Series F (a)(b) 164,720 3,786,542 
Adagio Theraputics, Inc.:   
Series A (b)(e) 90,362 6,259,376 
Series B (b)(e) 28,136 1,948,981 
Ambrx, Inc.:   
Series A (b)(e) 238,688 491,697 
Series B (b)(e) 214,819 442,527 
Element Biosciences, Inc. Series B (a)(b)(e) 250,956 1,887,189 
EQRx, Inc. Series B (b)(e) 1,415,792 4,700,429 
Inscripta, Inc. Series D (b)(e) 308,833 1,646,080 
Intarcia Therapeutics, Inc. Series EE (a)(b)(e) 116,544 2,117,604 
National Resilience, Inc. Series B (b)(e) 251,448 3,434,780 
  26,715,205 
Health Care Equipment & Supplies - 0.0%   
Kardium, Inc. Series D6 (b)(e) 1,136,853 1,154,861 
Health Care Providers & Services - 0.1%   
Conformal Medical, Inc. Series C (b)(e) 240,750 1,052,078 
Oscar Health, Inc. Series A-8 (a)(b)(e) 783,663 7,807,141 
Scorpion Therapeutics, Inc. Series B (b)(e) 242,077 585,688 
  9,444,907 
Health Care Technology - 0.0%   
PrognomIQ, Inc.:   
Series A5 (b)(e) 83,544 279,037 
Series B (b)(e) 198,721 663,728 
  942,765 
Pharmaceuticals - 0.0%   
Castle Creek Pharmaceutical Holdings, Inc.:   
Series B (a)(b)(e) 4,910 3,216,983 
Series C (a)(b)(e) 2,570 1,683,838 
Nohla Therapeutics, Inc. Series B (a)(b)(e) 3,126,919 31 
Vera Therapeutics, Inc. Series C (b)(e) 631,285 486,089 
  5,386,941 
TOTAL HEALTH CARE  43,644,679 
INDUSTRIALS - 0.2%   
Aerospace & Defense - 0.2%   
Space Exploration Technologies Corp. Series G (a)(b)(e) 53,937 22,653,001 
Professional Services - 0.0%   
YourPeople, Inc. Series C (a)(b)(e) 1,527,000 290,130 
TOTAL INDUSTRIALS  22,943,131 
INFORMATION TECHNOLOGY - 0.4%   
Communications Equipment - 0.0%   
Xsight Labs Ltd. Series D (b)(e) 167,386 1,338,418 
Electronic Equipment & Components - 0.0%   
Enevate Corp. Series E (b)(e) 814,561 903,091 
IT Services - 0.1%   
AppNexus, Inc. Series E (Escrow) (a)(b)(e) 209,665 6,567 
ByteDance Ltd. Series E1 (b)(e) 84,766 9,288,165 
Riskified Ltd.:   
Series D (b)(e) 34,100 392,150 
Series E (a)(b)(e) 155,000 1,782,500 
  11,469,382 
Software - 0.3%   
Bird Rides, Inc. (b)(e) 200,125 1,048,655 
Bird Rides, Inc.:   
Series C1 (b)(e) 117,022 613,195 
Series D (b)(e) 104,900 549,676 
Databricks, Inc. Series G (b)(e) 17,742 3,146,861 
Dataminr, Inc. Series D (a)(b)(e) 442,241 6,943,184 
Jet.Com, Inc. Series B1 (Escrow) (a)(b)(e) 2,105,094 21 
Nuvia, Inc. Series B (b)(e) 239,670 1,761,575 
Taboola.Com Ltd. Series E (a)(b) 331,426 8,418,220 
UiPath, Inc.:   
Series A1 (a)(b)(e) 156,981 9,776,111 
Series B1 (a)(b)(e) 7,821 487,059 
Series B2 (a)(b)(e) 38,946 2,425,392 
  35,169,949 
TOTAL INFORMATION TECHNOLOGY  48,880,840 
TOTAL CONVERTIBLE PREFERRED STOCKS  205,228,170 
Nonconvertible Preferred Stocks - 0.1%   
CONSUMER DISCRETIONARY - 0.0%   
Automobiles - 0.0%   
Neutron Holdings, Inc. Series 1D (b)(e) 5,678,726 84,045 
Waymo LLC Series A2 (b)(e) 10,731 921,441 
  1,005,486 
Specialty Retail - 0.0%   
Cazoo Holdings Ltd.:   
Series A (b)(e) 1,599 23,670 
Series B (b)(e) 27,995 414,403 
Series C (b)(e) 568 8,408 
Series D (b)(e) 100,010 1,480,423 
  1,926,904 
TOTAL CONSUMER DISCRETIONARY  2,932,390 
HEALTH CARE - 0.1%   
Pharmaceuticals - 0.1%   
Castle Creek Pharmaceutical Holdings, Inc. Series A4 (a)(b)(e) 13,511 8,852,272 
Faraday Pharmaceuticals, Inc. Series B (a)(b)(e) 219,824 455,036 
  9,307,308 
TOTAL NONCONVERTIBLE PREFERRED STOCKS  12,239,698 
TOTAL PREFERRED STOCKS   
(Cost $171,756,190)  217,467,868 
 Principal Amount Value 
Convertible Bonds - 0.0%   
CONSUMER DISCRETIONARY - 0.0%   
Automobiles - 0.0%   
Neutron Holdings, Inc.:   
4% 5/22/27 (b)(e) 857,900 857,900 
4% 6/12/27 (b)(e) 25,455 25,455 
TOTAL CONVERTIBLE BONDS   
(Cost $883,355)  883,355 
Preferred Securities - 0.0%   
HEALTH CARE - 0.0%   
Biotechnology - 0.0%   
Intarcia Therapeutics, Inc. 6% 7/18/21 (b)(e) 614,446 781,575 
Health Care Equipment & Supplies - 0.0%   
Kardium, Inc. 0% (b)(e)(g) 1,612,660 1,612,660 
TOTAL HEALTH CARE  2,394,235 
INFORMATION TECHNOLOGY - 0.0%   
Electronic Equipment & Components - 0.0%   
Enevate Corp. 0% 1/29/23 (b)(e) 346,804 346,804 
TOTAL PREFERRED SECURITIES   
(Cost $2,573,910)  2,741,039 
 Shares Value 
Money Market Funds - 4.4%   
Fidelity Cash Central Fund 0.07% (h) 380,219,213 380,295,257 
Fidelity Securities Lending Cash Central Fund 0.08% (h)(i) 204,407,669 204,428,110 
TOTAL MONEY MARKET FUNDS   
(Cost $584,723,367)  584,723,367 
TOTAL INVESTMENT IN SECURITIES - 101.4%   
(Cost $4,752,882,537)  13,690,402,543 
NET OTHER ASSETS (LIABILITIES) - (1.4)%(j)  (183,741,984) 
NET ASSETS - 100%  $13,506,660,559 

Futures Contracts      
 Number of contracts Expiration Date Notional Amount Value Unrealized Appreciation/(Depreciation) 
Purchased      
Equity Index Contracts      
CME E-mini S&P 500 Index Contracts (United States) 1,739 March 2021 $331,209,940 $(9,059,150) $(9,059,150) 

The notional amount of futures purchased as a percentage of Net Assets is 2.5%

Legend

 (a) Non-income producing

 (b) Restricted securities (including private placements) - Investment in securities not registered under the Securities Act of 1933 (excluding 144A issues). At the end of the period, the value of restricted securities (excluding 144A issues) amounted to $435,169,272 or 3.2% of net assets.

 (c) Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers. At the end of the period, the value of these securities amounted to $213,581,187 or 1.6% of net assets.

 (d) Security or a portion of the security is on loan at period end.

 (e) Level 3 security

 (f) Investment is owned by a wholly-owned subsidiary (Subsidiary) that is treated as a corporation for U.S. tax purposes.

 (g) Security is perpetual in nature with no stated maturity date.

 (h) Affiliated fund that is generally available only to investment companies and other accounts managed by Fidelity Investments. The rate quoted is the annualized seven-day yield of the fund at period end. A complete unaudited listing of the fund's holdings as of its most recent quarter end is available upon request. In addition, each Fidelity Central Fund's financial statements are available on the SEC's website or upon request.

 (i) Investment made with cash collateral received from securities on loan.

 (j) Includes $19,129,000 of cash collateral to cover margin requirements for futures contracts.

Additional information on each restricted holding is as follows:

Security Acquisition Date Acquisition Cost 
23andMe, Inc. Series F 8/31/17 $2,287,005 
Adagio Theraputics, Inc. Series A 7/15/20 $722,896 
Adagio Theraputics, Inc. Series B 11/4/20 $1,595,874 
Adimab LLC 9/17/14 - 6/5/15 $11,625,172 
Agbiome LLC Series C 6/29/18 $2,144,369 
Alignment Healthcare Partners unit 2/28/20 $2,835,368 
Allbirds, Inc. 10/9/18 $890,972 
Allbirds, Inc. Series A 10/9/18 $351,662 
Allbirds, Inc. Series B 10/9/18 $61,800 
Allbirds, Inc. Series C 10/9/18 $590,417 
Allbirds, Inc. Series D 12/23/19 $808,713 
Allbirds, Inc. Series Seed 10/9/18 - 1/23/20 $997,616 
Ambrx, Inc. Series A 11/6/20 $373,112 
Ambrx, Inc. Series B 11/6/20 $373,112 
Ant International Co. Ltd. Class C 5/16/18 $2,351,948 
AppHarvest, Inc. 1/29/21 $4,852,760 
AppNexus, Inc. Series E (Escrow) 8/1/14 $0 
Bird Rides, Inc. 2/12/21 $1,048,211 
Bird Rides, Inc. Series C1 12/21/18 $1,374,482 
Bird Rides, Inc. Series D 9/30/19 $1,355,067 
Blink Health, Inc. Series A1 12/30/20 $232,676 
Blink Health, Inc. Series C 11/7/19 - 1/21/21 $6,964,944 
BTRS Holdings, Inc. 1/12/21 $1,320,610 
ByteDance Ltd. Series E1 11/18/20 $9,288,165 
Castle Creek Pharmaceutical Holdings, Inc. Series A4 9/29/16 $4,471,547 
Castle Creek Pharmaceutical Holdings, Inc. Series B 10/9/18 $2,022,184 
Castle Creek Pharmaceutical Holdings, Inc. Series C 12/9/19 $1,058,455 
Cazoo Holdings Ltd. 9/30/20 $671,514 
Cazoo Holdings Ltd. Series A 9/30/20 $21,922 
Cazoo Holdings Ltd. Series B 9/30/20 $383,811 
Cazoo Holdings Ltd. Series C 9/30/20 $7,787 
Cazoo Holdings Ltd. Series D 9/30/20 $1,371,134 
Cerevel Therapeutics Holdings 10/27/20 $3,177,000 
Cibus Corp. Series C 2/16/18 - 5/10/19 $3,339,484 
Clover Health Investments Corp. 1/5/21 $2,026,000 
Coinbase, Inc. 2/25/21 - 2/26/21 $3,887,627 
Conformal Medical, Inc. Series C 7/24/20 $882,846 
Cyclerion Therapeutics, Inc. 4/2/19 $2,229,495 
Databricks, Inc. Series G 2/1/21 $3,146,861 
Dataminr, Inc. Series D 2/18/15 - 3/6/15 $5,638,573 
Dragonfly Therapeutics, Inc. 12/19/19 $3,336,950 
Element Biosciences, Inc. Series B 12/13/19 $1,315,160 
Enevate Corp. Series E 1/29/21 $903,092 
Enevate Corp. 0% 1/29/23 1/29/21 $346,804 
Epic Games, Inc. 7/13/20 - 7/30/20 $6,785,000 
EQRx, Inc. Series B 11/19/20 $3,881,960 
Fanatics, Inc. Series E 8/13/20 $2,208,313 
Faraday Pharmaceuticals, Inc. Series B 12/30/19 $288,996 
Freenome, Inc. Series C 8/14/20 $1,262,201 
Gemini Therapeutics, Inc. 2/5/21 $1,320,410 
Inscripta, Inc. Series D 11/13/20 $1,411,367 
Instacart, Inc. Series H 11/13/20 $834,240 
Instacart, Inc. Series I 2/26/21 $792,625 
Intarcia Therapeutics, Inc. Series EE 9/2/16 $6,992,640 
Intarcia Therapeutics, Inc. 6% 7/18/21 2/26/19 $614,446 
Jet.Com, Inc. Series B1 (Escrow) 3/19/18 $0 
JUUL Labs, Inc. Class A 7/6/18 $392,042 
JUUL Labs, Inc. Series E 7/6/18 $196,006 
Kardium, Inc. Series D6 12/30/20 $1,154,861 
Kardium, Inc. 0% 12/30/20 $1,612,660 
MOD Super Fast Pizza Holdings LLC Series 3 11/3/16 - 5/15/19 $3,367,295 
National Resilience, Inc. Series B 12/1/20 $3,434,780 
Neutron Holdings, Inc. Series 1D 1/25/19 $1,377,091 
Neutron Holdings, Inc. 4% 5/22/27 6/4/20 $857,900 
Neutron Holdings, Inc. 4% 6/12/27 6/12/20 $25,455 
Nohla Therapeutics, Inc. Series B 5/1/18 $1,123,581 
Nuvation Bio, Inc. 2/10/21 $4,231,840 
Nuvia, Inc. Series B 9/18/20 $768,705 
On Holding AG 2/6/20 $2,624,466 
Oscar Health, Inc. Series A-8 1/20/16 $5,293,448 
Paragon Biosciences Emalex Capital, Inc. Series B 9/18/19 $2,020,004 
Paragon Biosciences Emalex Capital, Inc. Series C 2/26/21 $1,238,974 
PrognomIQ, Inc. Series A5 8/20/20 $50,461 
PrognomIQ, Inc. Series B 9/11/20 $454,100 
QuantumScape Corp. 11/25/20 $1,738,980 
Rad Power Bikes, Inc. 1/21/21 $1,202,019 
Rad Power Bikes, Inc. Series A 1/21/21 $156,712 
Rad Power Bikes, Inc. Series C 1/21/21 $616,636 
Reddit, Inc. Series B 7/26/17 $538,544 
Riskified Ltd. 12/20/19 - 4/15/20 $1,773,844 
Riskified Ltd. Series D 11/18/20 $392,150 
Riskified Ltd. Series E 10/28/19 $1,474,732 
Riskified Ltd. warrants 10/28/19 $1 
Rivian Automotive, Inc. Series E 7/10/20 $9,688,236 
Rivian Automotive, Inc. Series F 1/19/21 $8,581,186 
Royalty Pharma PLC 5/21/15 $300,409 
Rush Street Interactive, Inc. 12/29/20 $1,025,550 
Scorpion Therapeutics, Inc. Series B 1/8/21 $585,688 
Seer, Inc. Class A 12/8/20 $1,433,227 
Skillz, Inc. 12/16/20 $1,063,700 
Sonder Holdings, Inc. Series D1 12/20/19 $2,785,793 
Sonder Holdings, Inc. Series E 4/3/20 - 5/6/20 $4,523,454 
Space Exploration Technologies Corp. Class A 10/16/15 - 4/6/17 $12,876,729 
Space Exploration Technologies Corp. Series G 1/20/15 $4,177,960 
Starry, Inc. Series B 12/1/16 $1,601,981 
Starry, Inc. Series C 12/8/17 $1,234,575 
Starry, Inc. Series D 3/6/19 $1,922,428 
Sweetgreen, Inc. Series C 9/13/19 $22,760 
Sweetgreen, Inc. Series D 9/13/19 $366,179 
Sweetgreen, Inc. Series H 11/9/18 $2,195,114 
Sweetgreen, Inc. Series I 9/13/19 $863,020 
Taboola.Com Ltd. Series E 12/22/14 $3,455,249 
The Honest Co., Inc. 8/21/14 $256,936 
The Honest Co., Inc. Series C 8/21/14 $599,509 
The Honest Co., Inc. Series D 8/3/15 $872,273 
Topgolf International, Inc. Series F 11/10/17 $3,237,994 
Tory Burch LLC 5/14/15 $17,489,925 
UiPath, Inc. Series A1 6/14/19 $2,059,156 
UiPath, Inc. Series B1 6/14/19 $102,590 
UiPath, Inc. Series B2 6/14/19 $510,864 
Vera Therapeutics, Inc. Series C 10/29/20 $373,594 
Waymo LLC Series A2 5/8/20 $921,441 
Wheels Up Partners Holdings LLC Series B 9/18/15 - 8/2/19 $11,335,416 
Xsight Labs Ltd. Series D 2/16/21 $1,338,418 
YourPeople, Inc. Series C 5/1/15 $22,753,949 
Yumanity Therapeutics, Inc. 12/22/20 $449,190 
Zomato Pvt Ltd. 1/22/21 - 1/29/21 $621,764 
Zomato Pvt Ltd. Series B 1/22/21 $24,690 
Zomato Pvt Ltd. Series E 1/22/21 $17 
Zomato Pvt Ltd. Series G 1/22/21 - 2/5/21 $169,015 
Zomato Pvt Ltd. Series J7 12/9/20 $1,262,621 
Zomato Pvt Ltd. Series K 2/10/21 $2,635,895 

Affiliated Central Funds

Information regarding fiscal year to date income earned by the Fund from investments in Fidelity Central Funds is as follows:

Fund Income earned 
Fidelity Cash Central Fund $35,861 
Fidelity Securities Lending Cash Central Fund 495,520 
Total $531,381 

Amounts in the income column in the above table include any capital gain distributions from underlying funds. Amount for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.

Investment Valuation

Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Security transactions are accounted for as of trade date. The Board of Trustees (the Board) has delegated the day to day responsibility for the valuation of the Fund's investments to the Fair Value Committee (the Committee) established by the Fund's investment adviser. In accordance with valuation policies and procedures approved by the Board, the Fund attempts to obtain prices from one or more third party pricing vendors or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with procedures adopted by the Board. Factors used in determining fair value vary by investment type and may include market or investment specific events, changes in interest rates and credit quality. The frequency with which these procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee oversees the Fund’s valuation policies and procedures and reports to the Board on the Committee's activities and fair value determinations. The Board monitors the appropriateness of the procedures used in valuing the Fund's investments and ratifies the fair value determinations of the Committee. The Fund categorizes the inputs to valuation techniques used to value its investments into a disclosure hierarchy consisting of three levels: Level 1 - quoted prices in active markets for identical investments: Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds etc.): Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available). Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy. Valuation techniques used to value the Fund's investments by major category are as follows:

Equity securities, including restricted securities, for which market quotations are readily available, are valued at the last reported sale price or official closing price as reported by a third party pricing vendor on the primary market or exchange on which they are traded and are categorized as Level 1 in the hierarchy. In the event there were no sales during the day or closing prices are not available, securities are valued at the last quoted bid price or may be valued using the last available price and are generally categorized as Level 2 in the hierarchy. For foreign equity securities, when market or security specific events arise, comparisons to the valuation of American Depositary Receipts (ADRs), futures contracts, Exchange-Traded Funds (ETFs) and certain indexes as well as quoted prices for similar securities may be used and would be categorized as Level 2 in the hierarchy. For equity securities, including restricted securities, where observable inputs are limited, assumptions about market activity and risk are used and these securities may be categorized as Level 3 in the hierarchy.  Securities, including private placements or other restricted securities, for which observable inputs are not available are valued using alternate valuation approaches, including the market approach, the income approach and cost approach are categorized as Level 3 in the hierarchy. The market approach considers factors including the price of recent investments in the same or a similar security or financial metrics of comparable securities. The income approach considers factors including expected future cash flows, security specific risks and corresponding discount rates. The cost approach considers factors including the value of the security’s underlying assets and liabilities. 

Debt securities, including restricted securities, are valued based on evaluated prices received from third party pricing vendors or from brokers who make markets in such securities. Corporate bonds and preferred securities are valued by pricing vendors who utilize matrix pricing which considers yield or price of bonds of comparable quality, coupon, maturity and type or by broker supplied prices.

When independent prices are unavailable or unreliable, debt securities may be valued utilizing pricing methodologies which consider similar factors that would be used by third party pricing vendors. Debt securities are generally categorized as Level 2 in the hierarchy but may be Level 3 depending on the circumstances.

Futures contracts are valued at the settlement price established each day by the board of trade or exchange on which they are traded and are categorized as Level 1 in the hierarchy.

Investments in open-end mutual funds, including the Fidelity Central Funds, are valued at their closing net asset value each business day and are categorized as Level 1 in the hierarchy.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.





The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.

Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.